DaVita's ROE % for the quarter that ended in Mar. 2026 was Negative Equity. DaVita's PB Ratio for the quarter that ended in Mar. 2026 was N/A.
DaVita's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2026 was Negative Equity.
DaVita ROE % Adjusted to Book Value Related Terms
DaVita ROE % Adjusted to Book Value Historical Data
* Premium members only.
The historical data trend for DaVita's ROE % Adjusted to Book Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MIL:1DVA vs THC, EHC, ENSG: ROE % Adjusted to Book Value Comparison
For the Medical Care Facilities subindustry, DaVita's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
DaVita ROE % Adjusted to Book Value vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, DaVita's ROE % Adjusted to Book Value distribution charts can be found below:
* The bar in red indicates where DaVita's ROE % Adjusted to Book Value falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a ROE % Adjusted to Book Value of Negative Equity% mean?
DaVita (MIL:1DVA) has a ROE % Adjusted to Book Value of Negative Equity% as of Mar. 2026. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on DaVita and its competitors.
Is DaVita's ROE % Adjusted to Book Value too high?
DaVita's current ROE % Adjusted to Book Value is Negative Equity%. Overall, DaVita has a GF Score™ of 61/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does DaVita's ROE % Adjusted to Book Value compare to THC and EHC?
DaVita's ROE % Adjusted to Book Value of Negative Equity% can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % Adjusted to Book Value for a Healthcare Providers & Services company?
A good ROE % Adjusted to Book Value depends on the Healthcare Providers & Services industry context. However, ROE % Adjusted to Book Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % Adjusted to Book Value mean?
A high ROE % Adjusted to Book Value can signal that a stock is expensive relative to its fundamentals. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on DaVita and its competitors. DaVita's current ROE % Adjusted to Book Value is Negative Equity%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is DaVita stock overvalued right now?
Based on GuruFocus' analysis, DaVita (MIL:1DVA) is currently considered Significantly Overvalued. The stock's GF Value™ is €148.57, compared to a current price of €207.10 — trading 39.4% above its estimated fair value. The current ROE % Adjusted to Book Value is Negative Equity%. DaVita's overall GF Score™ is 61/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % Adjusted to Book Value calculated?
ROE % Adjusted to Book Value is calculated from a company's financial statements. For DaVita (MIL:1DVA), the current ROE % Adjusted to Book Value is Negative Equity% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is DaVita (MIL:1DVA) Overvalued in 2026?
Based on GuruFocus' analysis, DaVita stock appears to be overvalued.
The current stock price of €207.10 is trading 39.4% above its estimated GF Value™ of €148.57.
GuruFocus considers DaVita to be Significantly Overvalued.
Key valuation signals for MIL:1DVA:
ROE % Adjusted to Book Value: Negative Equity%
GF Value™: €148.57 vs. price of €207.10 (39.4% above fair value)
No single metric tells the full story. See the MIL:1DVA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
DaVita is one of the largest providers of dialysis services in the United States, boasting a market share of about 35%. The firm operates over 3,200 facilities worldwide, mostly in the US, and treats about 300,000 patients annually. Government payers dominate US dialysis reimbursement. DaVita receives about two-thirds of US sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. While commercial insurers represent only about 10% of US patients treated, they represent nearly all of the profits generated by DaVita in the US dialysis business.
61GF Score
Get the complete analysis for MIL:1DVA
ROE % Adjusted to Book Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MIL:1DVA has been successfully added to your 
